Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-20

Clinical Trial Update: Resveratrol as a Preventive Treatment of OHSS [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating resveratrol as a preventive treatment for ovarian hyperstimulation syndrome (OHSS) in infertility, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resveratrol (resveratrol)

Snippet

Sponsor: IVI Madrid | Conditions: Infertility | Phase 3 | Status: COMPLETED